Stock Events

Stock Events

Fennec Pharmaceuticals 

$0
11
-$1,380-100% Friday 22:07

Statistics

Day High
-
Day Low
-
52W High
9.24
52W Low
5.6
Volume
-
Avg. Volume
212,316
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

10
SEP
Dividend Ex
Estimated
 
10
SEP 27
Dividend Ex
Estimated
 

Dividends

0%Dividend Yield
Sep 25
$0.03
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

1AprExpected
Q3 2024
Q1 2025
Q2 2025
Q3 2025
Next
-0.22
-0.13
-0.04
0.04
Expected EPS
0.0419508738
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ADH. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with Fennec Pharmaceuticals in the oncology sector, particularly in developing treatments for cancer-related conditions.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. is a leading pharmaceutical company that develops cancer therapies, directly competing with Fennec Pharmaceuticals' focus on oncology.
Novartis
NVS
Mkt Cap237.61B
Novartis AG competes in the pharmaceutical industry by offering a wide range of oncology drugs, which puts it in direct competition with Fennec Pharmaceuticals.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its pharmaceutical division Janssen, develops and markets oncology drugs, competing with Fennec Pharmaceuticals in the cancer treatment space.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is involved in the discovery, development, and marketing of cancer drugs, making it a competitor to Fennec Pharmaceuticals in the oncology field.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG, with its strong portfolio in oncology, competes with Fennec Pharmaceuticals in developing and marketing cancer treatments.
Astrazeneca
AZN
Mkt Cap256.58B
AstraZeneca PLC has a significant presence in the oncology sector, developing treatments that compete with Fennec Pharmaceuticals' cancer-focused therapies.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. is known for its innovative therapies in oncology, among other areas, competing with Fennec Pharmaceuticals in the cancer treatment market.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. focuses on human therapeutics, including oncology, which puts it in competition with Fennec Pharmaceuticals in the development of cancer treatments.
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Regeneron Pharmaceuticals, Inc. is involved in the development of oncology drugs, competing with Fennec Pharmaceuticals in the cancer therapy market.

About

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. The company's product candidates include PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity hearing loss in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Show more...
CEO
Mr. Rostislav Raykov
Employees
36
Country
CA

Listings

F
DE
RV41.F
BOATS
BOATS
FENC.BOATS
XNAS
US
FENC
TO
CA
FRX.TO

0 Comments

Share your thoughts

FAQ

What is Fennec Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Fennec Pharmaceuticals stocks are traded under the ticker ADH.
Is Fennec Pharmaceuticals stock price growing?▼
ADH stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Fennec Pharmaceuticals has showed a +23.83% increase.
Does Fennec Pharmaceuticals pay dividends?▼
Yes, ADH dividends are paid annual. The last dividend per share was 0.03 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Fennec Pharmaceuticals have?▼
As of April 01, 2026, the company has 36 employees.
In which sector is Fennec Pharmaceuticals located?▼
Fennec Pharmaceuticals operates in the Health Care sector.
When did Fennec Pharmaceuticals complete a stock split?▼
Fennec Pharmaceuticals has not had any recent stock splits.
Where is Fennec Pharmaceuticals headquartered?▼
Fennec Pharmaceuticals is headquartered in Research Triangle Park, CA.